nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0994	0.136	CbGbCtD
Cefaclor—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0886	0.121	CbGbCtD
Cefaclor—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0856	0.117	CbGbCtD
Cefaclor—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0789	0.108	CbGbCtD
Cefaclor—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0763	0.104	CbGbCtD
Cefaclor—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0753	0.103	CbGbCtD
Cefaclor—SLC15A1—Ramipril—type 2 diabetes mellitus	0.068	0.0929	CbGbCtD
Cefaclor—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0649	0.0886	CbGbCtD
Cefaclor—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0509	0.0695	CbGbCtD
Cefaclor—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0438	0.0599	CbGbCtD
Cefaclor—MPO—artery—type 2 diabetes mellitus	0.00188	0.194	CbGeAlD
Cefaclor—MPO—endothelium—type 2 diabetes mellitus	0.00158	0.164	CbGeAlD
Cefaclor—MPO—Vitamin B12 Metabolism—MAT1A—type 2 diabetes mellitus	0.00158	0.0334	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—MAT1A—type 2 diabetes mellitus	0.00129	0.0272	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—CBS—type 2 diabetes mellitus	0.00125	0.0263	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.00106	0.0223	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—CBS—type 2 diabetes mellitus	0.00101	0.0214	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A9—type 2 diabetes mellitus	0.000982	0.0207	CbGpPWpGaD
Cefaclor—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000807	0.0835	CbGeAlD
Cefaclor—MPO—Selenium Micronutrient Network—CBS—type 2 diabetes mellitus	0.000805	0.017	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—MTR—type 2 diabetes mellitus	0.000803	0.0169	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—HBA1—type 2 diabetes mellitus	0.000782	0.0165	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—INSR—type 2 diabetes mellitus	0.000773	0.0163	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—F7—type 2 diabetes mellitus	0.000746	0.0157	CbGpPWpGaD
Cefaclor—SLC15A1—kidney—type 2 diabetes mellitus	0.000709	0.0733	CbGeAlD
Cefaclor—MPO—Vitamin B12 Metabolism—PLAT—type 2 diabetes mellitus	0.000665	0.014	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—MTR—type 2 diabetes mellitus	0.000653	0.0138	CbGpPWpGaD
Cefaclor—MPO—cardiovascular system—type 2 diabetes mellitus	0.000652	0.0674	CbGeAlD
Cefaclor—MPO—kidney—type 2 diabetes mellitus	0.000638	0.066	CbGeAlD
Cefaclor—MPO—Folate Metabolism—HBA1—type 2 diabetes mellitus	0.000636	0.0134	CbGpPWpGaD
Cefaclor—MPO—pancreas—type 2 diabetes mellitus	0.000634	0.0656	CbGeAlD
Cefaclor—MPO—Folate Metabolism—INSR—type 2 diabetes mellitus	0.000629	0.0133	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—F7—type 2 diabetes mellitus	0.000607	0.0128	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—SOD1—type 2 diabetes mellitus	0.000542	0.0114	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—PLAT—type 2 diabetes mellitus	0.000541	0.0114	CbGpPWpGaD
Cefaclor—SLC15A2—retina—type 2 diabetes mellitus	0.000535	0.0554	CbGeAlD
Cefaclor—MPO—Selenium Micronutrient Network—MTR—type 2 diabetes mellitus	0.000519	0.0109	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—HBA1—type 2 diabetes mellitus	0.000506	0.0107	CbGpPWpGaD
Cefaclor—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000504	0.0522	CbGeAlD
Cefaclor—MPO—Vitamin B12 Metabolism—APOB—type 2 diabetes mellitus	0.0005	0.0105	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—INSR—type 2 diabetes mellitus	0.000499	0.0105	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—SOD2—type 2 diabetes mellitus	0.000488	0.0103	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—F7—type 2 diabetes mellitus	0.000482	0.0102	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—NOS2—type 2 diabetes mellitus	0.000482	0.0102	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000473	0.00998	CbGpPWpGaD
Cefaclor—SLC15A1—liver—type 2 diabetes mellitus	0.000448	0.0464	CbGeAlD
Cefaclor—SLC15A2—kidney—type 2 diabetes mellitus	0.000443	0.0459	CbGeAlD
Cefaclor—MPO—Folate Metabolism—SOD1—type 2 diabetes mellitus	0.000441	0.00931	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000439	0.00926	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—CCL2—type 2 diabetes mellitus	0.000435	0.00917	CbGpPWpGaD
Cefaclor—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000432	0.0447	CbGeAlD
Cefaclor—MPO—Selenium Micronutrient Network—PLAT—type 2 diabetes mellitus	0.00043	0.00907	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—MTHFR—type 2 diabetes mellitus	0.00043	0.00907	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—CAT—type 2 diabetes mellitus	0.000419	0.00884	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—CRP—type 2 diabetes mellitus	0.000409	0.00863	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—APOB—type 2 diabetes mellitus	0.000407	0.00858	CbGpPWpGaD
Cefaclor—MPO—liver—type 2 diabetes mellitus	0.000403	0.0417	CbGeAlD
Cefaclor—MPO—Vitamin B12 Metabolism—APOE—type 2 diabetes mellitus	0.0004	0.00844	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—SOD2—type 2 diabetes mellitus	0.000397	0.00838	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—APOA1—type 2 diabetes mellitus	0.000396	0.00835	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—PIK3R1—type 2 diabetes mellitus	0.000388	0.00818	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—GPX1—type 2 diabetes mellitus	0.000379	0.00799	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—ICAM1—type 2 diabetes mellitus	0.000376	0.00793	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—RELA—type 2 diabetes mellitus	0.000365	0.0077	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—SOD1—type 2 diabetes mellitus	0.00035	0.00739	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—MTHFR—type 2 diabetes mellitus	0.00035	0.00738	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—INS—type 2 diabetes mellitus	0.000342	0.00721	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000341	0.00719	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—CCL2—type 2 diabetes mellitus	0.000336	0.0071	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—CAT—type 2 diabetes mellitus	0.000333	0.00702	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—CRP—type 2 diabetes mellitus	0.000333	0.00702	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—GSTM1—type 2 diabetes mellitus	0.000326	0.00688	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—APOB—type 2 diabetes mellitus	0.000323	0.00682	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—APOA1—type 2 diabetes mellitus	0.000322	0.00679	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	0.000316	0.00667	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—SOD2—type 2 diabetes mellitus	0.000316	0.00666	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000316	0.00666	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—SERPINE1—type 2 diabetes mellitus	0.000314	0.00662	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—ALB—type 2 diabetes mellitus	0.000313	0.00661	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—NFKB1—type 2 diabetes mellitus	0.000308	0.00649	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—ICAM1—type 2 diabetes mellitus	0.000306	0.00645	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000305	0.00643	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—GPX1—type 2 diabetes mellitus	0.000301	0.00635	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000293	0.00618	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000283	0.00597	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—RELA—type 2 diabetes mellitus	0.000282	0.00595	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—INS—type 2 diabetes mellitus	0.000278	0.00587	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—MTHFR—type 2 diabetes mellitus	0.000278	0.00586	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—CCL2—type 2 diabetes mellitus	0.000274	0.00577	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—CRP—type 2 diabetes mellitus	0.000264	0.00558	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—APOA1—type 2 diabetes mellitus	0.000256	0.00539	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—SERPINE1—type 2 diabetes mellitus	0.000255	0.00539	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—ALB—type 2 diabetes mellitus	0.000255	0.00538	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000248	0.00524	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—ICAM1—type 2 diabetes mellitus	0.000243	0.00512	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00024	0.00507	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—TNF—type 2 diabetes mellitus	0.000239	0.00505	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000239	0.00504	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—NFKB1—type 2 diabetes mellitus	0.000238	0.00502	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000231	0.00486	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—RELA—type 2 diabetes mellitus	0.00023	0.00484	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000223	0.00471	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000222	0.00468	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—INS—type 2 diabetes mellitus	0.000221	0.00466	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	0.000217	0.00459	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000203	0.00429	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	0.000203	0.00428	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—ALB—type 2 diabetes mellitus	0.000203	0.00427	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000197	0.00415	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000196	0.00414	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—BCL2—type 2 diabetes mellitus	0.000194	0.00408	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—NFKB1—type 2 diabetes mellitus	0.000194	0.00408	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL6—type 2 diabetes mellitus	0.000193	0.00407	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000189	0.00398	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	0.000185	0.0039	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—PTGS2—type 2 diabetes mellitus	0.000184	0.00388	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	0.000182	0.00385	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000182	0.00384	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	0.000177	0.00374	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000163	0.00345	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.00016	0.00338	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000156	0.00329	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000155	0.00327	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000155	0.00327	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	0.000154	0.00324	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000152	0.00321	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000152	0.0032	CbGpPWpGaD
Cefaclor—Cefpiramide—ALB—type 2 diabetes mellitus	0.000151	0.256	CrCbGaD
Cefaclor—MPO—Folate Metabolism—TNF—type 2 diabetes mellitus	0.000151	0.00318	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	0.000149	0.00315	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000149	0.00314	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000145	0.00305	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000144	0.00303	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000144	0.00303	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000142	0.00299	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000141	0.00298	CbGpPWpGaD
Cefaclor—Cefonicid—ALB—type 2 diabetes mellitus	0.000132	0.223	CrCbGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000131	0.00277	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000127	0.00267	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000126	0.00266	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000126	0.00266	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—IL6—type 2 diabetes mellitus	0.000122	0.00256	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000122	0.00256	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000122	0.00256	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000121	0.00256	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	0.00012	0.00252	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000119	0.00252	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000117	0.00248	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000117	0.00247	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000117	0.00247	CbGpPWpGaD
Cefaclor—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000116	0.000553	CcSEcCtD
Cefaclor—Rash—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000552	CcSEcCtD
Cefaclor—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000551	CcSEcCtD
Cefaclor—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000116	0.000551	CcSEcCtD
Cefaclor—Headache—Glimepiride—type 2 diabetes mellitus	0.000116	0.00055	CcSEcCtD
Cefaclor—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000116	0.000549	CcSEcCtD
Cefaclor—Cough—Irbesartan—type 2 diabetes mellitus	0.000116	0.000549	CcSEcCtD
Cefaclor—Headache—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000548	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000115	0.000544	CcSEcCtD
Cefaclor—Agitation—Losartan—type 2 diabetes mellitus	0.000115	0.000544	CcSEcCtD
Cefaclor—Oedema—Metformin—type 2 diabetes mellitus	0.000115	0.000544	CcSEcCtD
Cefaclor—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000542	CcSEcCtD
Cefaclor—Angioedema—Losartan—type 2 diabetes mellitus	0.000114	0.000541	CcSEcCtD
Cefaclor—Insomnia—Valsartan—type 2 diabetes mellitus	0.000114	0.00054	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000113	0.000538	CcSEcCtD
Cefaclor—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000113	0.000536	CcSEcCtD
Cefaclor—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000113	0.000536	CcSEcCtD
Cefaclor—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000113	0.000535	CcSEcCtD
Cefaclor—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000535	CcSEcCtD
Cefaclor—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000535	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000113	0.00238	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000113	0.00238	CbGpPWpGaD
Cefaclor—Shock—Metformin—type 2 diabetes mellitus	0.000113	0.000535	CcSEcCtD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000113	0.00238	CbGpPWpGaD
Cefaclor—Insomnia—Orlistat—type 2 diabetes mellitus	0.000112	0.000534	CcSEcCtD
Cefaclor—Malaise—Losartan—type 2 diabetes mellitus	0.000112	0.000534	CcSEcCtD
Cefaclor—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000112	0.000534	CcSEcCtD
Cefaclor—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000112	0.000533	CcSEcCtD
Cefaclor—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000112	0.000533	CcSEcCtD
Cefaclor—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000112	0.000532	CcSEcCtD
Cefaclor—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000112	0.000532	CcSEcCtD
Cefaclor—Vertigo—Losartan—type 2 diabetes mellitus	0.000112	0.000532	CcSEcCtD
Cefaclor—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000112	0.000532	CcSEcCtD
Cefaclor—Somnolence—Valsartan—type 2 diabetes mellitus	0.000112	0.000531	CcSEcCtD
Cefaclor—Syncope—Losartan—type 2 diabetes mellitus	0.000112	0.000531	CcSEcCtD
Cefaclor—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000112	0.00053	CcSEcCtD
Cefaclor—Leukopenia—Losartan—type 2 diabetes mellitus	0.000112	0.00053	CcSEcCtD
Cefaclor—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000111	0.000529	CcSEcCtD
Cefaclor—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000111	0.000527	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000111	0.00234	CbGpPWpGaD
Cefaclor—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000111	0.000526	CcSEcCtD
Cefaclor—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000111	0.000526	CcSEcCtD
Cefaclor—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000524	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.00011	0.00233	CbGpPWpGaD
Cefaclor—Palpitations—Losartan—type 2 diabetes mellitus	0.00011	0.000523	CcSEcCtD
Cefaclor—Nausea—Glimepiride—type 2 diabetes mellitus	0.00011	0.000521	CcSEcCtD
Cefaclor—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00011	0.00052	CcSEcCtD
Cefaclor—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00011	0.00052	CcSEcCtD
Cefaclor—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000109	0.000519	CcSEcCtD
Cefaclor—Asthenia—Glyburide—type 2 diabetes mellitus	0.000109	0.000519	CcSEcCtD
Cefaclor—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000109	0.000519	CcSEcCtD
Cefaclor—Anorexia—Metformin—type 2 diabetes mellitus	0.000109	0.000518	CcSEcCtD
Cefaclor—Cough—Losartan—type 2 diabetes mellitus	0.000109	0.000516	CcSEcCtD
Cefaclor—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000109	0.000516	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000109	0.000516	CcSEcCtD
Cefaclor—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000108	0.000514	CcSEcCtD
Cefaclor—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000108	0.000514	CcSEcCtD
Cefaclor—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000108	0.000513	CcSEcCtD
Cefaclor—Oedema—Irbesartan—type 2 diabetes mellitus	0.000108	0.000513	CcSEcCtD
Cefaclor—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000108	0.000513	CcSEcCtD
Cefaclor—Pruritus—Glyburide—type 2 diabetes mellitus	0.000108	0.000512	CcSEcCtD
Cefaclor—Constipation—Valsartan—type 2 diabetes mellitus	0.000108	0.000511	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000107	0.000509	CcSEcCtD
Cefaclor—Hypotension—Metformin—type 2 diabetes mellitus	0.000107	0.000508	CcSEcCtD
Cefaclor—Shock—Irbesartan—type 2 diabetes mellitus	0.000106	0.000505	CcSEcCtD
Cefaclor—Pain—Orlistat—type 2 diabetes mellitus	0.000106	0.000505	CcSEcCtD
Cefaclor—Myalgia—Losartan—type 2 diabetes mellitus	0.000106	0.000504	CcSEcCtD
Cefaclor—Chest pain—Losartan—type 2 diabetes mellitus	0.000106	0.000504	CcSEcCtD
Cefaclor—Arthralgia—Losartan—type 2 diabetes mellitus	0.000106	0.000504	CcSEcCtD
Cefaclor—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000503	CcSEcCtD
Cefaclor—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000106	0.000503	CcSEcCtD
Cefaclor—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000503	CcSEcCtD
Cefaclor—Anxiety—Losartan—type 2 diabetes mellitus	0.000106	0.000502	CcSEcCtD
Cefaclor—Rash—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000499	CcSEcCtD
Cefaclor—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000499	CcSEcCtD
Cefaclor—Tension—Ramipril—type 2 diabetes mellitus	0.000105	0.000498	CcSEcCtD
Cefaclor—Discomfort—Losartan—type 2 diabetes mellitus	0.000105	0.000498	CcSEcCtD
Cefaclor—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000105	0.000496	CcSEcCtD
Cefaclor—Headache—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000496	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000104	0.000495	CcSEcCtD
Cefaclor—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000104	0.000495	CcSEcCtD
Cefaclor—Nervousness—Ramipril—type 2 diabetes mellitus	0.000104	0.000493	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000103	0.00218	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000103	0.00218	CbGpPWpGaD
Cefaclor—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000489	CcSEcCtD
Cefaclor—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000103	0.000488	CcSEcCtD
Cefaclor—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000103	0.000488	CcSEcCtD
Cefaclor—Confusional state—Losartan—type 2 diabetes mellitus	0.000103	0.000487	CcSEcCtD
Cefaclor—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000102	0.000486	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000102	0.00216	CbGpPWpGaD
Cefaclor—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000102	0.000485	CcSEcCtD
Cefaclor—Somnolence—Metformin—type 2 diabetes mellitus	0.000102	0.000483	CcSEcCtD
Cefaclor—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000102	0.000483	CcSEcCtD
Cefaclor—Oedema—Losartan—type 2 diabetes mellitus	0.000102	0.000483	CcSEcCtD
Cefaclor—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000102	0.000483	CcSEcCtD
Cefaclor—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000101	0.00048	CcSEcCtD
Cefaclor—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000101	0.000479	CcSEcCtD
Cefaclor—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000101	0.000479	CcSEcCtD
Cefaclor—Tremor—Ramipril—type 2 diabetes mellitus	0.0001	0.000475	CcSEcCtD
Cefaclor—Shock—Losartan—type 2 diabetes mellitus	0.0001	0.000475	CcSEcCtD
Cefaclor—Urticaria—Valsartan—type 2 diabetes mellitus	0.0001	0.000474	CcSEcCtD
Cefaclor—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.98e-05	0.000474	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	9.98e-05	0.00211	CbGpPWpGaD
Cefaclor—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.96e-05	0.000473	CcSEcCtD
Cefaclor—Decreased appetite—Metformin—type 2 diabetes mellitus	9.96e-05	0.000473	CcSEcCtD
Cefaclor—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.95e-05	0.000472	CcSEcCtD
Cefaclor—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.92e-05	0.000471	CcSEcCtD
Cefaclor—Nausea—Bromocriptine—type 2 diabetes mellitus	9.91e-05	0.00047	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.89e-05	0.00047	CcSEcCtD
Cefaclor—Urticaria—Orlistat—type 2 diabetes mellitus	9.88e-05	0.000469	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.85e-05	0.000468	CcSEcCtD
Cefaclor—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.84e-05	0.000467	CcSEcCtD
Cefaclor—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000467	CcSEcCtD
Cefaclor—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000467	CcSEcCtD
Cefaclor—Asthenia—Gliclazide—type 2 diabetes mellitus	9.83e-05	0.000466	CcSEcCtD
Cefaclor—Agitation—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000466	CcSEcCtD
Cefaclor—Constipation—Metformin—type 2 diabetes mellitus	9.8e-05	0.000465	CcSEcCtD
Cefaclor—Angioedema—Ramipril—type 2 diabetes mellitus	9.77e-05	0.000464	CcSEcCtD
Cefaclor—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.000461	CcSEcCtD
Cefaclor—Anorexia—Losartan—type 2 diabetes mellitus	9.7e-05	0.00046	CcSEcCtD
Cefaclor—Vomiting—Glyburide—type 2 diabetes mellitus	9.7e-05	0.00046	CcSEcCtD
Cefaclor—Pruritus—Gliclazide—type 2 diabetes mellitus	9.69e-05	0.00046	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	9.65e-05	0.00204	CbGpPWpGaD
Cefaclor—Malaise—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000458	CcSEcCtD
Cefaclor—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000458	CcSEcCtD
Cefaclor—Rash—Glyburide—type 2 diabetes mellitus	9.62e-05	0.000456	CcSEcCtD
Cefaclor—Somnolence—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.000456	CcSEcCtD
Cefaclor—Dermatitis—Glyburide—type 2 diabetes mellitus	9.61e-05	0.000456	CcSEcCtD
Cefaclor—Vertigo—Ramipril—type 2 diabetes mellitus	9.61e-05	0.000456	CcSEcCtD
Cefaclor—Syncope—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000455	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	9.59e-05	0.00202	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	9.57e-05	0.00202	CbGpPWpGaD
Cefaclor—Leukopenia—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000454	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	9.57e-05	0.00202	CbGpPWpGaD
Cefaclor—Headache—Glyburide—type 2 diabetes mellitus	9.56e-05	0.000454	CcSEcCtD
Cefaclor—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.52e-05	0.000452	CcSEcCtD
Cefaclor—Hypotension—Losartan—type 2 diabetes mellitus	9.51e-05	0.000451	CcSEcCtD
Cefaclor—Palpitations—Ramipril—type 2 diabetes mellitus	9.45e-05	0.000448	CcSEcCtD
Cefaclor—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.44e-05	0.000448	CcSEcCtD
Cefaclor—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.4e-05	0.000446	CcSEcCtD
Cefaclor—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000446	CcSEcCtD
Cefaclor—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.37e-05	0.000445	CcSEcCtD
Cefaclor—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.37e-05	0.000445	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.000443	CcSEcCtD
Cefaclor—Cough—Ramipril—type 2 diabetes mellitus	9.33e-05	0.000443	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.27e-05	0.00044	CcSEcCtD
Cefaclor—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.27e-05	0.00044	CcSEcCtD
Cefaclor—Convulsion—Ramipril—type 2 diabetes mellitus	9.26e-05	0.00044	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	9.26e-05	0.00195	CbGpPWpGaD
Cefaclor—Pain—Irbesartan—type 2 diabetes mellitus	9.25e-05	0.000439	CcSEcCtD
Cefaclor—Constipation—Irbesartan—type 2 diabetes mellitus	9.25e-05	0.000439	CcSEcCtD
Cefaclor—Insomnia—Losartan—type 2 diabetes mellitus	9.2e-05	0.000437	CcSEcCtD
Cefaclor—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.16e-05	0.000435	CcSEcCtD
Cefaclor—Paraesthesia—Losartan—type 2 diabetes mellitus	9.14e-05	0.000434	CcSEcCtD
Cefaclor—Urticaria—Metformin—type 2 diabetes mellitus	9.1e-05	0.000432	CcSEcCtD
Cefaclor—Chest pain—Ramipril—type 2 diabetes mellitus	9.1e-05	0.000432	CcSEcCtD
Cefaclor—Myalgia—Ramipril—type 2 diabetes mellitus	9.1e-05	0.000432	CcSEcCtD
Cefaclor—Arthralgia—Ramipril—type 2 diabetes mellitus	9.1e-05	0.000432	CcSEcCtD
Cefaclor—Dyspnoea—Losartan—type 2 diabetes mellitus	9.07e-05	0.000431	CcSEcCtD
Cefaclor—Anxiety—Ramipril—type 2 diabetes mellitus	9.07e-05	0.000431	CcSEcCtD
Cefaclor—Nausea—Glyburide—type 2 diabetes mellitus	9.06e-05	0.00043	CcSEcCtD
Cefaclor—Abdominal pain—Metformin—type 2 diabetes mellitus	9.06e-05	0.00043	CcSEcCtD
Cefaclor—Dizziness—Gliclazide—type 2 diabetes mellitus	9.06e-05	0.00043	CcSEcCtD
Cefaclor—Somnolence—Losartan—type 2 diabetes mellitus	9.05e-05	0.000429	CcSEcCtD
Cefaclor—Asthenia—Valsartan—type 2 diabetes mellitus	9.03e-05	0.000428	CcSEcCtD
Cefaclor—Discomfort—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000427	CcSEcCtD
Cefaclor—Dyspepsia—Losartan—type 2 diabetes mellitus	8.96e-05	0.000425	CcSEcCtD
Cefaclor—Asthenia—Orlistat—type 2 diabetes mellitus	8.92e-05	0.000423	CcSEcCtD
Cefaclor—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.91e-05	0.000423	CcSEcCtD
Cefaclor—Pruritus—Valsartan—type 2 diabetes mellitus	8.9e-05	0.000423	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	8.88e-05	0.00187	CbGpPWpGaD
Cefaclor—Decreased appetite—Losartan—type 2 diabetes mellitus	8.85e-05	0.00042	CcSEcCtD
Cefaclor—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.84e-05	0.00042	CcSEcCtD
Cefaclor—Confusional state—Ramipril—type 2 diabetes mellitus	8.8e-05	0.000418	CcSEcCtD
Cefaclor—Pruritus—Orlistat—type 2 diabetes mellitus	8.8e-05	0.000418	CcSEcCtD
Cefaclor—Oedema—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000414	CcSEcCtD
Cefaclor—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000414	CcSEcCtD
Cefaclor—Vomiting—Gliclazide—type 2 diabetes mellitus	8.71e-05	0.000413	CcSEcCtD
Cefaclor—Pain—Losartan—type 2 diabetes mellitus	8.7e-05	0.000413	CcSEcCtD
Cefaclor—Constipation—Losartan—type 2 diabetes mellitus	8.7e-05	0.000413	CcSEcCtD
Cefaclor—Rash—Gliclazide—type 2 diabetes mellitus	8.64e-05	0.00041	CcSEcCtD
Cefaclor—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.63e-05	0.000409	CcSEcCtD
Cefaclor—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.61e-05	0.000409	CcSEcCtD
Cefaclor—Urticaria—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.000408	CcSEcCtD
Cefaclor—Shock—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000407	CcSEcCtD
Cefaclor—Headache—Gliclazide—type 2 diabetes mellitus	8.58e-05	0.000407	CcSEcCtD
Cefaclor—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000406	CcSEcCtD
Cefaclor—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000406	CcSEcCtD
Cefaclor—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000406	CcSEcCtD
Cefaclor—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000406	CcSEcCtD
Cefaclor—Cefradine—CYP3A4—type 2 diabetes mellitus	8.54e-05	0.144	CrCbGaD
Cefaclor—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.51e-05	0.000404	CcSEcCtD
Cefaclor—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.44e-05	0.0004	CcSEcCtD
Cefaclor—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.39e-05	0.000398	CcSEcCtD
Cefaclor—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.32e-05	0.000395	CcSEcCtD
Cefaclor—Dizziness—Valsartan—type 2 diabetes mellitus	8.32e-05	0.000395	CcSEcCtD
Cefaclor—Anorexia—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000395	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	8.3e-05	0.00175	CbGpPWpGaD
Cefaclor—Dizziness—Orlistat—type 2 diabetes mellitus	8.22e-05	0.00039	CcSEcCtD
Cefaclor—Asthenia—Metformin—type 2 diabetes mellitus	8.22e-05	0.00039	CcSEcCtD
Cefaclor—Hypotension—Ramipril—type 2 diabetes mellitus	8.15e-05	0.000387	CcSEcCtD
Cefaclor—Nausea—Gliclazide—type 2 diabetes mellitus	8.14e-05	0.000386	CcSEcCtD
Cefaclor—Pruritus—Metformin—type 2 diabetes mellitus	8.11e-05	0.000385	CcSEcCtD
Cefaclor—Urticaria—Losartan—type 2 diabetes mellitus	8.09e-05	0.000384	CcSEcCtD
Cefaclor—Body temperature increased—Losartan—type 2 diabetes mellitus	8.05e-05	0.000382	CcSEcCtD
Cefaclor—Abdominal pain—Losartan—type 2 diabetes mellitus	8.05e-05	0.000382	CcSEcCtD
Cefaclor—Vomiting—Valsartan—type 2 diabetes mellitus	8e-05	0.00038	CcSEcCtD
Cefaclor—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000378	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.95e-05	0.000377	CcSEcCtD
Cefaclor—Rash—Valsartan—type 2 diabetes mellitus	7.93e-05	0.000377	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	7.93e-05	0.00167	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	7.93e-05	0.00167	CbGpPWpGaD
Cefaclor—Dermatitis—Valsartan—type 2 diabetes mellitus	7.93e-05	0.000376	CcSEcCtD
Cefaclor—Vomiting—Orlistat—type 2 diabetes mellitus	7.91e-05	0.000375	CcSEcCtD
Cefaclor—Insomnia—Ramipril—type 2 diabetes mellitus	7.89e-05	0.000375	CcSEcCtD
Cefaclor—Headache—Valsartan—type 2 diabetes mellitus	7.88e-05	0.000374	CcSEcCtD
Cefaclor—Diarrhoea—Metformin—type 2 diabetes mellitus	7.84e-05	0.000372	CcSEcCtD
Cefaclor—Rash—Orlistat—type 2 diabetes mellitus	7.84e-05	0.000372	CcSEcCtD
Cefaclor—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.84e-05	0.000372	CcSEcCtD
Cefaclor—Dermatitis—Orlistat—type 2 diabetes mellitus	7.83e-05	0.000372	CcSEcCtD
Cefaclor—Headache—Orlistat—type 2 diabetes mellitus	7.79e-05	0.00037	CcSEcCtD
Cefaclor—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.78e-05	0.000369	CcSEcCtD
Cefaclor—Asthenia—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000368	CcSEcCtD
Cefaclor—Somnolence—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000368	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	7.74e-05	0.00163	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	7.71e-05	0.00163	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	7.69e-05	0.00162	CbGpPWpGaD
Cefaclor—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000365	CcSEcCtD
Cefaclor—Pruritus—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000363	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	7.65e-05	0.00161	CbGpPWpGaD
Cefaclor—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.59e-05	0.00036	CcSEcCtD
Cefaclor—Dizziness—Metformin—type 2 diabetes mellitus	7.58e-05	0.00036	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000358	CcSEcCtD
Cefaclor—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.5e-05	0.000356	CcSEcCtD
Cefaclor—Nausea—Valsartan—type 2 diabetes mellitus	7.47e-05	0.000355	CcSEcCtD
Cefaclor—Constipation—Ramipril—type 2 diabetes mellitus	7.46e-05	0.000354	CcSEcCtD
Cefaclor—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.000351	CcSEcCtD
Cefaclor—Nausea—Orlistat—type 2 diabetes mellitus	7.39e-05	0.000351	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	7.36e-05	0.00155	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	7.36e-05	0.00155	CbGpPWpGaD
Cefaclor—Asthenia—Losartan—type 2 diabetes mellitus	7.3e-05	0.000347	CcSEcCtD
Cefaclor—Vomiting—Metformin—type 2 diabetes mellitus	7.29e-05	0.000346	CcSEcCtD
Cefaclor—Rash—Metformin—type 2 diabetes mellitus	7.23e-05	0.000343	CcSEcCtD
Cefaclor—Dermatitis—Metformin—type 2 diabetes mellitus	7.22e-05	0.000343	CcSEcCtD
Cefaclor—Pruritus—Losartan—type 2 diabetes mellitus	7.2e-05	0.000342	CcSEcCtD
Cefaclor—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.19e-05	0.000341	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	7.18e-05	0.00151	CbGpPWpGaD
Cefaclor—Headache—Metformin—type 2 diabetes mellitus	7.18e-05	0.000341	CcSEcCtD
Cefaclor—Dizziness—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000339	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	7.14e-05	0.00151	CbGpPWpGaD
Cefaclor—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000339	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	7.1e-05	0.0015	CbGpPWpGaD
Cefaclor—Diarrhoea—Losartan—type 2 diabetes mellitus	6.96e-05	0.00033	CcSEcCtD
Cefaclor—Urticaria—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000329	CcSEcCtD
Cefaclor—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000327	CcSEcCtD
Cefaclor—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000327	CcSEcCtD
Cefaclor—Vomiting—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.000326	CcSEcCtD
Cefaclor—Rash—Irbesartan—type 2 diabetes mellitus	6.82e-05	0.000324	CcSEcCtD
Cefaclor—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.81e-05	0.000323	CcSEcCtD
Cefaclor—Nausea—Metformin—type 2 diabetes mellitus	6.81e-05	0.000323	CcSEcCtD
Cefaclor—Headache—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000322	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	6.74e-05	0.00142	CbGpPWpGaD
Cefaclor—Dizziness—Losartan—type 2 diabetes mellitus	6.73e-05	0.000319	CcSEcCtD
Cefaclor—Ampicillin—ALB—type 2 diabetes mellitus	6.61e-05	0.112	CrCbGaD
Cefaclor—Vomiting—Losartan—type 2 diabetes mellitus	6.47e-05	0.000307	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	6.43e-05	0.00136	CbGpPWpGaD
Cefaclor—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000305	CcSEcCtD
Cefaclor—Nausea—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000305	CcSEcCtD
Cefaclor—Rash—Losartan—type 2 diabetes mellitus	6.42e-05	0.000305	CcSEcCtD
Cefaclor—Dermatitis—Losartan—type 2 diabetes mellitus	6.41e-05	0.000304	CcSEcCtD
Cefaclor—Headache—Losartan—type 2 diabetes mellitus	6.38e-05	0.000303	CcSEcCtD
Cefaclor—Asthenia—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000297	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	6.26e-05	0.00132	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	6.25e-05	0.00132	CbGpPWpGaD
Cefaclor—Pruritus—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000293	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.16e-05	0.0013	CbGpPWpGaD
Cefaclor—Nausea—Losartan—type 2 diabetes mellitus	6.05e-05	0.000287	CcSEcCtD
Cefaclor—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000283	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.97e-05	0.00126	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.8e-05	0.00122	CbGpPWpGaD
Cefaclor—Dizziness—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000274	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.72e-05	0.00121	CbGpPWpGaD
Cefaclor—Vomiting—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000263	CcSEcCtD
Cefaclor—Cephalexin—CYP3A4—type 2 diabetes mellitus	5.53e-05	0.0935	CrCbGaD
Cefaclor—Rash—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000261	CcSEcCtD
Cefaclor—Dermatitis—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000261	CcSEcCtD
Cefaclor—Headache—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000259	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.31e-05	0.00112	CbGpPWpGaD
Cefaclor—Cefalotin—ALB—type 2 diabetes mellitus	5.3e-05	0.0897	CrCbGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.29e-05	0.00112	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.24e-05	0.00111	CbGpPWpGaD
Cefaclor—Nausea—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000246	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.07e-05	0.00107	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.93e-05	0.00104	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.91e-05	0.00104	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.86e-05	0.00103	CbGpPWpGaD
Cefaclor—Cephalexin—ALB—type 2 diabetes mellitus	4.82e-05	0.0816	CrCbGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.74e-05	0.000999	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.7e-05	0.000992	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.4e-05	0.000927	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.27e-05	0.000901	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.01e-05	0.000846	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.97e-05	0.000837	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.72e-05	0.000785	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.18e-05	0.00067	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.95e-05	0.000622	CbGpPWpGaD
